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Abstract
There is mounting evidence to suggest that the synthesis of pre-mRNA transcripts and their subsequent splicing are
coordinated events. Previous studies have implicated the mammalian spliceosomal U2 snRNP as having a novel role in
stimulating transcriptional elongation in vitro through interactions with the elongation factors P-TEFb and Tat-SF1; however,
the mechanism remains unknown [1]. These factors are conserved in Saccharomyces cerevisiae, a fact that suggests that a
similar interaction may occur in yeast to stimulate transcriptional elongation in vivo. To address this possibility we have
looked for evidence of a role for the yeast Tat-SF1 homolog, Cus2, and the U2 snRNA in regulating transcription. Specifically,
we have performed a genetic analysis to look for functional interactions between Cus2 or U2 snRNA and the P-TEFb yeast
homologs, the Bur1/2 and Ctk1/2/3 complexes. In addition, we have analyzed Cus2-deleted or -overexpressing cells and U2
snRNA mutant cells to determine if they show transcription-related phenotypes similar to those displayed by the P-TEFb
homolog mutants. In no case have we been able to observe phenotypes consistent with a role for either spliceosomal factor
in transcription elongation. Furthermore, we did not find evidence for physical interactions between the yeast U2 snRNP
factors and the P-TEFb homologs. These results suggest that in vivo, S. cerevisiae do not exhibit functional or physical
interactions similar to those exhibited by their mammalian counterparts in vitro. The significance of the difference between
our in vivo findings and the previously published in vitro results remains unclear; however, we discuss the potential
importance of other factors, including viral proteins, in mediating the mammalian interactions.
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Introduction
Removal of introns from eukaryotic pre-mRNA is carried out by
a large, dynamic macromolecular machine called the spliceosome.
Although pre-mRNA splicing was once thought to be a distinct
biochemical process, work in the last 10 years has done much to
demonstrate that pre-mRNA splicing can occur co-transcriptionally
as the pre-mRNA is being transcribed by RNA polymerase II
(RNAPII). The temporal and spatial coordination of these processes
affords the opportunity for factors involved in each process to
influence the other. Indeed, recent work has established that
molecular and functional interactions take place between the
RNAPII elongation complex and the RNA splicing machinery [2–
4].Theseinteractionsworktocoordinatethetwoprocesseswithone
another in a manner that is thought to ensure efficient production
and processing of mRNA. Understanding how these processes are
coordinated is crucial for understanding gene expression.
The polymerase carboxyl-terminal domain (CTD) is important
for coordinating pre-mRNA splicing and transcription. The CTD
has been shown to physically interact with splicing factors and to
positively regulate splicing in vitro and in vivo [4,5]. Post-translational
modifications of the polymerase CTD by kinases, phosphatases, and
prolyl isomerases have been shown to affect co-transcriptional
splicing through multiple mechanisms (for reviews see [6–9]).
The mammalian kinase complex P-TEFb (positive transcription
elongation factor b) is an essential regulator of transcription
elongation and has multiple roles in coordinating transcription and
pre-mRNA processing [10,11]. P-TEFb, comprising CDK9 and
its associated cyclin T1, facilitates release of stalled RNAPII into
productive elongation through a variety of mechanisms, including
inhibition of transcriptional repressors, recruitment of positive
elongation factors, and phosphorylation of the polymerase CTD at
Serine 2 of its heptapeptide repeat, a modification associated with
productive elongation. These activities are required for recruit-
ment of splicing factors to the site of active transcription and
stimulation of co-transcriptional splicing [12–15].
The role of P-TEFb at the interface of splicing and transcription
was highlighted by an important report in 2001 [1]. Here it was
demonstrated that immunoprecipitates of P-TEFb containing the
elongation factor Tat-SF1 (Tat stimulatory factor 1) and
spliceosomal snRNPs stimulated transcriptional elongation of a
human immunodeficiency virus-1 (HIV-1) template. The stimu-
latory effect was dependent upon the ability of Tat-SF1 to
associate with both P-TEFb and the U2 snRNA. This finding
suggested a novel role for Tat-SF1 and the U2 snRNP in
stimulating transcription. However, the detailed mechanism
underlying this stimulatory effect remains unknown, and it is not
clear if this interaction occurs in vivo in mammalian cells.
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16077The yeast homolog of Tat-SF1, Cus2, has been characterized in
yeast as a U2 snRNP-associated splicing factor. Tat-SF1 and CUS2
share 46% sequence identity, and the proteins each contain two
RNA recognition motifs (RRMs), as well as an acidic C-terminal
domain [16]. The homology between CUS2 and Tat-SF1 has
raised the intriguing question of whether Cus2 has a role in
regulating transcription. Recently it was shown that deletion of
CUS2 reduced influenza RNA synthesis in yeast cells infected with
viral ribonucleoprotein complex (vRNP) components [17]. Since
Tat-SF1 knockdown in influenza-infected mammalian cells
affected formation of vRNP particles, independent of RNA
synthesis or processing, these studies raised the possibility that
Cus2 could be playing a similar role as a chaperone for viral RNP
assembly. This study also raised the question of whether Cus2 is
capable of exhibiting a stimulatory effect on transcription similar
to that reported for Tat-SF1. And, since the yeast cells in this
report were infected with viral components, this study raised the
question of whether the effects observed are specific to viral
systems or are indicative of a more general role for Cus2 in
transcription.
Although a direct role for Tat-SF1 in regulating splicing is yet to
be determined, the role for CUS2 in splicing has been well
characterized. The U2 snRNA of yeast and humans is very
similar, with the exception of a unique, 945 nucleotide fungal stem
loop which is dispensable for the RNA’s role in splicing [18]. The
highly conserved 59 end of the U2 snRNA can adopt multiple
secondary structures at several steps during the splicing cycle [19–
26]. Regulated formation of these structures is required for both
spliceosome assembly and the catalysis of splicing. During
spliceosome assembly, Cus2 recognizes and binds the IIc
conformation of the U2 snRNA and, along with the helicase
Prp5, facilitates its refolding into the IIa conformation. Formation
of the U2-IIa structure activates the snRNP and allows for its
stable association with the pre-mRNA [19,24–26] (see also
Figure 1). The ability of Cus2 to facilitate U2 snRNA folding is
abrogated by a mutation within one of its RRMs that abolishes U2
snRNA binding in vitro [16]. A corresponding mutation in Tat-SF1
has been shown to disrupt the protein-snRNP interaction
necessary to enhance elongation. This raises the possibility that
the ability of Tat-SF1 to associate with the U2 snRNP, perhaps
mediated by the snRNA’s secondary structure, is responsible for
the effects on elongation [1]. Notably, in mammals the U1 snRNA
has been shown to stimulate transcription initiation by TFIIH, a
result which suggests a precedent for spliceosomal snRNAs in
affecting transcriptional events [27].
In addition to the homology between CUS2 and Tat-SF1, S.
cerevisiae also possess factors homologous to P-TEFb. The cyclin-
dependent kinases (CDKs) Bur and Ctk exhibit equivalent levels of
sequence homology with P-TEFb [28] and, like P-TEFb, are
important for regulating several aspects of transcription. Hence, it
has been proposed that together the Bur and Ctk complexes
reconstitute the activity of their mammalian counterpart [10,29].
However, a detailed functional analysis of several metazoan CDKs
suggest that Bur1 and its associated cyclin Bur2 are orthologous to
the metazoan Cdk9/cyclin T1, while Ctk1 and its cyclin are
actually orthologs of the metazoan Ctk12/cyclin K [30]. The yeast
Bur and Ctk complexes appear to facilitate transcriptional
elongation at the 59 and 39 ends of genes, respectively, through
a variety of mechanisms including CTD phosphorylation and
chromatin modification (for review see [29]). The Bur1 kinase is
required for efficient elongation by the polymerase and phosphor-
ylates the CTD of RNAPII at Serine 2 near the promoter of genes
[31] and at Serine 7 [32]. The Bur complex also acts by targeting
non-CTD substrates to regulate histone modification [33,34] and
to suppress cryptic transcription [35]. The Ctk complex consisting
of the Ctk1 kinase, its associated Ctk2 cyclin, and a third
regulatory protein, Ctk3, is also required for elongation by the
polymerase, phosphorylates Serine 2 of the CTD, and regulates
histone H3 trimethylation [36–39].
Strong sequence conservation of P-TEFb, Tat-SF1, and the U2
snRNA from mammals to simpler eukaryotes supports the idea
that the mechanism whereby P-TEFb and Tat-SF1/U2 snRNA
interact to affect elongation may be conserved throughout
evolution. To address this possibility, we analyzed the relationship
of the homologous factors in yeast. We hypothesized that, if a
similar interaction exists in yeast, disruption of either CUS2 or the
U2 snRNA would result in the same transcription-related
phenotypes exhibited by perturbation of the CDKs. Furthermore,
we predicted that these factors would physically associate in a
manner similar to their mammalian counterparts.
We performed a genetic analysis in Saccharomyces cerevisiae to
investigate the in vivo relationship of the CDKs and the U2 snRNP
components, Cus2 and U2 snRNA. We find that neither mutating
CUS2 nor the U2 snRNA exhibit genetic interactions with the Bur
or Ctk complexes. In addition, mutations of the U2 snRNP
components do not exhibit phenotypes that have been used
previously to assess the roles of P-TEFb homologs in transcription;
these phenotypes include sensitivity to 6-azauracil (6-AU), inositol
auxotrophy, and the Spt
2 or Bur
2 phenotypes. Finally, we were
unable to detect physical interactions between these factors. Taken
together, we find a lack of evidence for a functional complex
containing the yeast CDK complexes and the U2 snRNP. These
results suggest that if P-TEFb associates with Tat-SF1 and the U2
snRNA to stimulate transcription in vivo, these interactions are not
conserved in yeast.
Results
Neither the Tat-SF1 yeast homolog CUS2 nor the U2
snRNA exhibits genetic interactions with the yeast
homologs of P-TEFb
Cus2 and the U2 snRNP interact to stabilize secondary
structures of the U2 snRNA that are important for spliceosome
assembly (Figure 1). In light of evidence that the mammalian Tat-
SF1 interacts with snRNPs and has functional interactions with P-
TEFb, we considered the possibility that Cus2 and U2 could also
affect transcription via interactions with the P-TEFb homologs. To
address this possibility, we began by examining genetic interac-
tions between CUS2 and transcription factors, particularly the
putative P-TEFb homologs.
Synthetic interactions (such as synthetic lethality) are a hallmark
behavior of genes involved in a common function [40]. Not
surprisingly, CUS2 deletion exhibits synthetic interactions with
genes encoding other splicing factors including the U2 snRNA and
several proteins associated with U2 snRNPs including Prp5 and
Cus1 [16,23,41]. Similarly, deletion of components of the CDK
complexes leads to severe synthetic growth defects when combined
with deletion or mutation of factors involved in transcriptional
elongation, including TFIIS, the Spt4/5 complex, and the CTD of
RNAPII [33,37,39,42–45]. We predicted that if the Bur or Ctk
complexes shared a functional overlap with CUS2, as is the case
with P-TEFb and Tat-SF1, we might observe synthetic mutant
phenotypes when mutations in the Bur or Ctk complexes were
combined with deletion of CUS2.
To address this possibility, we crossed a cus2D strain with both
bur2D and ctk2D strains and then analyzed the double mutant
progeny (Figure 2). BUR2 and CTK2 are both non-essential
components of their P-TEFb-like complexes. Deletion of BUR2 or
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and results in phenotypes consistent with their roles in transcrip-
tion [46,47]. The growth rate of a cus2D mutant is similar to that of
wild type cells; whereas a bur2D mutant shows a significant growth
defect (Figure 2A). This slow growth phenotype is unchanged in
the cus2D bur2Dstrain. Similarly, deletion of CTK2 results in a slow
growth phenotype that is unaffected by CUS2 deletion (Figure 2B).
Unlike other factors that contribute to Bur or Ctk activity and
reveal this through synthetic interactions, we find no evidence of
such a relationship between the CDKs and CUS2.
The ability of P-TEFb and Tat-SF1 to physically interact with
the U snRNAs, particularly the U2 snRNA was shown to be
crucial for the stimulatory effect on transcription. Since Cus2 has
been shown to specifically associate with the U2-IIc conformation,
we hypothesized that U2 snRNA mutants that preferentially form
or disrupt this structure might play a functional role in
transcription elongation and that this might be revealed by genetic
interactions with the CDKs.
To determine whether Bur or Ctk complex function is
influenced by a particular conformation of the U2 snRNA, bur2D
and ctk2D strains were each crossed with a strain in which the
genomic U2 (SNR20) gene was deleted and the U2 snRNA gene
was harbored on a plasmid. Mutant U2 snRNA alleles were
introduced to the resultant double mutant strains by plasmid
shuffling. These previously characterized U2 snRNA plasmids
encoded alleles that preferentially form either the U2-IIc or IIa
conformation [16,19–21,23–25]. The U2-IIc allele consists of a
G53 to A mutation that favors the U2-IIc conformation by
abrogating the formation of the essential IIa stem-loop. The U2-
IIa allele hyperstabilizes the essential IIa stem-loop element by
deletion of the region of phylogenetically conserved complemen-
tarity to stem-loop IIa combined with conversion of the AU stem-
pairs to more thermodynamically stable GC pairs (Figure 1B).
As previously reported, in a wild-type background, the U2-IIc
allele confers a slow growth phenotype (Figure 2C) consistent with
its defect in splicing (data not shown). However, the U2-IIa allele
confers no growth defect (Figure 2C) or splicing defect (data not
shown). Expression of the mutant U2-IIa or U2-IIc snRNA allele
does not alter the growth of bur2D (Figure 2C). Similarly, the slow-
growth phenotype conferred by CTK2 deletion is not altered by
the U2 structural mutants (Figure 2C). These data suggest that,
like CUS2, neither the U2-IIc nor the U2-IIa conformation
displays functional overlap with the Bur or Ctk complexes.
Because of the orthologous relationship between the Bur complex
and the P-TEFb complex, we looked closely at a variety of
readouts associated with Bur complex function.
Neither changes in Cus2 levels nor alteration of U2
snRNA conformation confer the transcription-related
phenotypes of the P-TEFb homologs
Deletion of BUR2 results in several phenotypes that are classic
indicators of defects in transcription, including sensitivity to the
drug 6-azauracil (6-AU) [46,48]. Treatment of cells with 6-AU
results in nucleotide depletion and enhances the requirement for a
fully functioning transcription apparatus for efficient transcription
[49]. Hence, genes encoding transcription elongation factors are
often required for cell viability in the presence of 6-azauracil. If
CUS2 is involved in regulating transcription elongation through
interactions with the Bur complex, then it is likely that CUS2 will
also exhibit this phenotype or affect the 6-AU sensitivity of bur2
mutants.
Figure 1. Cus2 facilitates refolding of mutually exclusive structures of the U2 snRNA. (A) Model of Cus2’s activity toward the U2 snRNA.
Cus2 recognizes and binds the U2-IIc snRNA conformation and facilitates its rearrangement into the U2-IIa conformation. Formation of the U2-IIa
conformation activates the snRNP (depicted as a ball) and allows for its stable association with the pre-mRNA substrate to form the pre-spliceosome
with the U1 snRNP. The exons of the pre-mRNA are depicted as filled boxes and the intron is depicted as a line. (B) Diagram of the 59 portion of yeast
U2 snRNA mutually exclusive U2-IIc and U2-IIa conformations. The U2 snRNA mutants used in this study promote either U2-IIc or U2-IIa as indicated.
The G53 position is shaded red. The sequences that base pair to form the U2-IIc stem are shaded in blue.
doi:10.1371/journal.pone.0016077.g001
The Yeast U2 snRNP and Transcription
PLoS ONE | www.plosone.org 3 January 2011 | Volume 6 | Issue 1 | e16077To determine whether CUS2 deletion confers 6-AU sensitivity
or affects the 6-AU sensitivity of bur2D, we analyzed growth of
cus2D and cus2D bur2D on media containing 6-AU. Deletion of
BUR2 alone results in sensitivity to 6-AU (Figure 3A). However,
deletion of CUS2 exhibits no 6-AU sensitive phenotype alone, nor
does this mutation exacerbate the 6-AU sensitivity of bur2D cells as
seen in the double mutant.
Because factors involved in the same pathways are sometimes
able to compensate for one another when overexpressed [50] we
considered the possibility that the Bur complex and CUS2 acted in
the same pathway such that deletion of one gene masked the
phenotype associated with deletion of the other. To determine
whether CUS2 overexpression could compensate for the lack of
BUR2, we generated strains in which CUS2 was overexpressed on
a high-copy 2m plasmid. This allele was HA-tagged, and
overexpression of the Cus2 protein was confirmed by western
blot analysis using antibodies directed against the epitope (data not
shown). CUS2 overexpression does not affect the growth of the
strains tested when compared to the vector alone (Figure 3B).
Furthermore, overexpression of CUS2 was not able to suppress the
slow growth phenotype conferred by BUR2 deletion. Next, we
tested the ability of CUS2 overexpression to suppress the 6-AU
sensitivity of BUR2 deletion. CUS2 overexpression does not confer
6-AU sensitivity in wild type or cus2D cells nor does overexpression
suppress the 6-AU sensitivity of bur2D cells (Figure 3B).
To determine whether particular U2 snRNA conformations
exhibit sensitivity to 6-AU or affect bur2D 6-AU sensitivity, the
double mutant strains were grown in the presence and absence of
the drug (Figure 3C). In the WT background, neither the IIa nor
the IIc U2 snRNA allele exhibits slow growth in the presence of 6-
AU. Moreover, neither U2 snRNA mutant affected the 6-AU
sensitivity of the double mutant. These data indicate that U2
snRNA is not able to compensate for loss of Bur2 in the presence
6-AU.
In addition to sensitivity to 6-AU, deletion of BUR2 confers
inositol auxotrophy, a phenotype that is often correlated with
defects in transcription [46,48,51]. Mutation of particular
components of the general transcription machinery including
BUR1 and BUR2, can lead to defects in the expression of INO1,
the gene encoding inositol-1-phosphate synthase that converts
glucose-6-phosphate into inositol. As a result, these mutant strains
are unable to grow in the absence of inositol in the media.
To determine whether, like BUR2, CUS2 or the U2 snRNA
confers the Ino
2 phenotype, the single mutant strains of each were
Figure 2. Neither Cus2 nor the U2 snRNA exhibits genetic interactions with p-TEFb-associated cyclin homologs. (A) Analysis of bur2D
cus2D double mutant. The indicated strains were grown in YPD and four ten-fold serial dilutions were spotted onto YPD plates and grown at 30uC for
3 days. (B) Analysis of ctk2D cus2D double mutant. Cells were treated as described in (A). (C) Analysis of the U2 snRNA conformational mutants. Strains
harboring the wild-type U2 snRNA (URA3 plasmids, pRS316) and the indicated mutant snRNA (LEU2 plasmids, pRS315) were grown in selective SC-
ura-leu media and four ten-fold serial dilutions were spotted onto 5-FOA-Leu to select for loss of the wild-type U2 snRNA URA3-marked plasmid.
Plates were grown at 30uC for the indicated number of days.
doi:10.1371/journal.pone.0016077.g002
The Yeast U2 snRNP and Transcription
PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e16077grown on media lacking inositol. As previously described, the
bur2D strain is unable to grow under these conditions (Figure 3).
Unlike bur2D, strains in which CUS2 is deleted or overexpressed
grow similarly to the wild type strain in the absence of inositol and
do not exhibit the Ino
2 phenotype. Furthermore, neither deletion
nor overexpression of CUS2 alters the Ino
2 phenotype of the
double mutant bur2D cus2D strain. Similarly, the U2-IIa and U2-
IIc mutants do not exhibit inositol auxotrophy, nor are they able to
suppress this phenotype of the bur2D strain. Taken together, these
data indicate that neither CUS2 nor the U2 snRNA exhibit the 6-
AU sensitivity or inositol auxotrophy shared by BUR2 and other
transcription factor mutant strains.
The U2 snRNP does not exhibit genetic interactions with
other general transcription factors
It is possible that the U2 snRNP may affect transcription but
that in vivo this activity may only be revealed under certain
conditions. The role for the Bur and Ctk complexes has been
characterized, in part, by their genetic interactions with other
components of the transcription apparatus. To address whether a
U2 snRNP function in transcription can be revealed through
functional interactions with elongation factors, we performed a
targeted genetic screen between CUS2 or the U2 snRNA and
factors known to interact with the CDKs. Here, we looked for
synthetic interactions between the splicing factors and the
elongation factor TFIIS (DST1), which is synthetically lethal in
combination with bur2D [52]; SPT4 whose activity is regulated by
the Bur complex [43]; and LEO1, a nonessential member of the
PAF complex [52,53] responsible for regulating histone modifica-
tions that promote active transcription. For comparison, we
analyzed genetic interactions between the individual transcription
elongation factors as well. The results of this screen along with
previously published results are summarized in Table 1.
Deletion of BUR2 is synthetically lethal in combination with
deletion of either CTK2 or CTK3, a fact that highlights the high
degree of functional overlap between these complexes. Both the
Bur and Ctk complexes are dependent upon an intact polymerase
CTD (Rpb1), as mutations in the components of either CDK have
previously been shown to be inviable in combination with rpb1
truncation alleles [43,45]. Similarly, combining dst1D with
mutations in the CDKs causes a severe synthetic growth defect.
In contrast, neither the rpb1 CTD truncations combined with
CUS2 deletion nor the dst1D cus2D double mutants display
synthetic growth defects (Table 1). Similarly, the U2 snRNA
mutants we tested did not display interactions with DST1.
In addition to their roles in phosphorylation of the CTD of
RNA polymerase, the Bur and Ctk complexes regulate transcrip-
tion in part through interactions with the Spt4-Spt5 complex.
Figure 3. Phenotypic analysis of bur2D double mutant strains. (A) CUS2 deletion does not confer sensitivity to 6-AU or inositol auxotrophy.
Strains used in these studies were transformed with pRS316 (URA3) to allow for growth on media containing 6-azauracil (6-AU). Serial dilutions of the
indicated strains were spotted onto solid media medium lacking uracil (Control), in the presence of 6-AU (100 mg/ml), or on media lacking inositol (-
INO) and incubated at 30uC for 3–6 days. (B) CUS2 overexpression does not confer 6-AU sensitivity, inositol auxotrophy, or suppress these phenotypes
of bur2D. The indicated strains carrying URA3-marked plasmids (vector or CUS2 on a 2m plasmid) were grown in SC-uracil and four ten-fold serial
dilutions were spotted onto solid media medium lacking uracil (Control), in the presence of 6-AU (100 mg/ml), or on media lacking inositol (-INO) and
incubated at 30uC for 3–6 days. (C) U2 snRNA mutants do not exhibit sensitivity to 6-AU and are not auxotrophic for inositol. Mutant snRNAs were
introduced into the indicated strains by plasmid shuffling. Strains were then re-transformed with pRS316 (URA3) and spotted onto the indicated
media. Plates were grown at 30uC for the indicated number of 3–6 days.
doi:10.1371/journal.pone.0016077.g003
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mammalian counterparts interact with P-TEFb [54]. Both SPT4
and SPT5 are required for efficient transcription elongation and
have been implicated as having roles in coupling transcription and
splicing [55]. SPT4 exhibits genetic interactions with BUR2, CTK2,
DST1 and the polymerase [43,52]. However, unlike these known
transcription factors, we find no similar interaction between SPT4
and either deletion of CUS2 or its overexpression.
Leo1 is a component of the PAF elongation complex that
regulates transcription elongation via its role in histone modifica-
tion. LEO1 and other PAF subunits exhibit interactions with both
the Bur and the Ctk complex [35,44,52,53,56–58]. Conversely, we
found that leo1D cells exhibited no synthetic growth defect when
combined with the U2 snRNA alleles.
As is the case with bur2D cells, deletion of DST1, LEO1,o r
SPT4 renders cells sensitive to 6-AU, thus indicating their roles
in regulating transcription [53,59,60]. To determine whether U2
snRNA alleles affect the 6-AU sensitivity of these strains we
tested the growth of the double mutants on medium containing
6-AU. Alterations in the U2 snRNA secondary structure failed to
produce significant changes in the 6-AU sensitivity of these
strains (data not shown and Table 1). Taken together, the
genetic analyses summarized in Table 1 suggest that neither
CUS2 nor the U2 snRNA conformation mutants exhibit
functional overlap with transcription factors that interact with
the CDK complexes.
Neither changes in Cus2 levels nor alteration of U2
snRNA conformation exhibits Bur
2 or Spt
2 phenotypes
BUR1 and BUR2 were initially identified in a screen for mutants
that exhibited increased transcription of the SUC2 gene in the
absence of its upstream activating sequence (UAS) [61]. Deletion
of the SUC2 upstream activating sequence (suc2Duas) abolishes
transcription of this gene and, as a result, prevents growth on
media containing sucrose as the carbon source. Mutations that
bypass the UAS requirement exhibit the Bur
2 phenotype and
increase transcription from suc2Duas [48]. We hypothesized that if
the U2 snRNP components are involved in Bur complex activity at
core promoters, mutations in CUS2 or U2 snRNA should also
exhibit the Bur
2 phenotype. To test this hypothesis, we generated
double mutant strains harboring the suc2Duas mutation and CUS2
deletion or the SNR20 deletion complemented by a U2 snRNA
allele on a plasmid. The resulting strains were tested for their
ability to grow on sucrose plates. The bur2-1 mutant strain was
able to grow on sucrose plates as previously reported, while the
cus2D, CUS2 overexpressing, U2-IIa and U2-IIc snRNA mutant
strains each failed to grow on sucrose plates (Table 1). These
results suggest that, unlike mutations in BUR2, these splicing factor
mutants cannot bypass the requirement for the UAS for
transcription.
The Suppressor of Ty (SPT) genes were originally identified by
their ability to genetically suppress the transcriptional defects
conferred by Ty element insertion [61]. Strains harboring a d Ty
element in the HIS4 gene promoter are His
2 but in the presence of
spt mutations become His
+. The spt mutants suppress transcrip-
tional defects through several different mechanisms, all involving
alteration of transcription. Mutations in SPT4, SPT5, BUR1 and
BUR2 confer Spt
2 phenotypes indicative of their roles in
regulating transcription events [60,61]. Specific mutations in
either component of the Bur complex have been found to exhibit
Spt
2 phenotypes [33,45,46,48,62]. For example, the bur2-1
mutant is Spt
2 and overexpression of the bur1-3 allele exhibits a
dominant negative Spt
2 phenotype. If the U2 snRNP exhibits
functional overlap with the Bur complex, then CUS2 or the U2
snRNA may also confer the Spt
2 phenotype.
To test this we generated double mutant strains of these
factors and the his4-912d mutant. The resultant double mutants
were assayed for their ability to grow on plates lacking histidine.
As previously described, the bur2-1 mutant suppresses the his4-
912d ty insertion mutation and allows for growth on media
lacking histidine (Figure 4). Conversely, neither CUS2 deletion
(Figure 4A) nor overexpression (Figure 4B) restored growth on
media lacking histidine. Similarly, the U2 snRNA mutants did
not grow on media lacking histidine and did not exhibit an Spt
2
phenotype similar to mutations in BUR2 (Figure 4C). These
studies suggest that, unlike the Bur complex, these splicing
factors are unable to affect transcription from promoters
disrupted by a Ty insertion.
Table 1. Summary of phenotypic analysis of cus2D and U2 snRNA mutants compared to select transcription elongation factors.
bur2D ctk2D ctk3D cus2D U2 IIa U2 IIc
Haploid growth ++ +++ +++ ++++ ++++ +++
6-Azauracil 2 ND, ctk1D 6-AU
s [71] ND, ctk1D 6-AU
s [71] ++++ ++++ +++
Bypass UAS Yes [61] No No No No No
GENETIC INTERACTIONS
bur2D
ckt2D SL
ctk3D SL SGD
cus2D No SGD No SGD No SGD
U2 IIa No SGD No SGD No SGD No SGD
U2 IIc No SGD No SGD No SGD SL ND
CTD truncation ND, bur1-2 SGD [45] ND, ctk1D SGD [45] ND, ctk1D SGD [45] No SGD ND ND
dst1D SGD [43] SGD SGD [72] No SGD No SGD No SGD
leo1D SGD [35] SGD [72] ND, ctk1DSGD [53,72] ND No SGD No SGD
spt4D SL [52] ND, ctk1DSGD [43] ND, ctk1D SGD [43] ND No SGD No SGD
SGD, Synthetic Growth Defect; SL, Synthetically lethal; 6-AU
s, 6-azauracil sensitive; ND, Not Determined.
doi:10.1371/journal.pone.0016077.t001
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with the Bur complex
The mammalian study of the role of Tat-SF1 in in vitro
transcription demonstrated that Tat-SF1 and accompanying U2
snRNP associated with P-TEFb via interactions with its cyclin
subunit T1 [1]. If a parallel interaction exists in yeast, then we
would expect to detect physical interactions between the
homologous cyclin Bur2 and both Cus2 and U2 snRNA.
To determine whether Bur2 physically interacts with Cus2 or the
U2 snRNA we performed co-immunoprecipitation experiments.
Co-immunoprecipitations were performed using TAP-tagged Bur2
strains in which a 66His epitope-tagged Cus2 is expressed from the
GAL1 promoter on a plasmid, and Cus2 production was induced by
growth ingalactosefor threehours.Thisallowed us to enrich forthe
Cus2 protein available for immunoprecipitation or co-immunopre-
cipitatation. Under these conditions Cus2 overexpression produced
no detectable phenotype and complementation tests have shown
that the 66His epitope did not interfere with the function of Cus2
(data not shown and personal communication, M. Ares). We have
demonstrated that Bur1 and Bur2 co-immunoprecipitate (data not
shown) indicating that the Bur2 pulldown used in these studies
represents pulldown of both factors. ParallelCus2-His or Bur2-TAP
immunoprecipitates were split and examined for protein interac-
tions with Bur2 or Cus2, respectively, by western and for protein-
RNA interactions by primer extension. Initial experiments failed to
detect an interaction between Bur2 and either the U2 snRNA or
Cus2. However, if an in vivo interaction exists but is weak, transient,
or occurs relatively infrequently, the interaction may be difficult to
detect using this method. To address this possibility, we used in vivo
formaldehyde cross-linking to enrich for weak interactions.
As expected, we observe physical interactions between Cus2 and
the U2 snRNA in the anti-His precipitates (Figure 5). This
interaction is specific for the U2 snRNA, although we detect some
U1 snRNA that may represent an interaction with Cus2 and the
prespliceosome. Although Cus2 shows positive interactions with
these spliceosomal snRNAs, we failed to detect the Bur2 protein in
Figure 4. Neither Cus2 nor the U2 snRNA exhibits an Spt
2 phenotype. The strains used in this study all contain the his4-912d mutation. bur2-
1 has been previously characterized as Spt
2 (A) The indicated strains were grown in YPD and four ten-fold serial dilutions spotted onto media
containing (Control) or lacking histidine (-His) and grown at 30uC for 5 days. (B) The indicated strains carrying URA3-marked plasmids (vector or CUS2
on a 2m plasmid) were grown in SC-uracil and four ten-fold serial dilutions were spotted onto SC-uracil (Control) or onto media lacking uracil and
histidine (-His) and incubated at 30uC for 5 days. (C) Mutant snRNAs were introduced into the indicated strains by plasmid shuffling. Strains were
grown overnight in SC-leu medium and plated onto SC-leu (Control) or SC-leu-his (-His) media. Plates were grown at 30uC for 5 days.
doi:10.1371/journal.pone.0016077.g004
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snRNA were detected in the Bur2-TAP immunoprecipitate. These
data suggest that, although Cus2 is able to interact with the U2
snRNA under the conditions tested, these interactions do not occur
in the context of a larger complex containing the Bur complex and
are therefore distinct from those interactions reported in metazoans.
Discussion
Previous studies have suggested that transcription and splicing
are functionally coupled. A key prediction of this model is that
specific transcription factors and splicing factors physically interact
and that these interactions would affect splicing, transcription, or
both. Mammalian studies have demonstrated such a relationship
between the transcriptional elongation factors P-TEFb and Tat-
SF1 [1]. The experiments described here set out to determine
whether the yeast homologs of P-TEFb and components of the U2
snRNP have similar physical and functional interactions. We find
that the U2 snRNP components do not affect transcription in a
detectable way. Furthermore, we were unable to detect physical
interactions between the U2 snRNP components and the P-TEFb
homologs. Taken together, we find a lack of evidence for a
functional interaction between the P-TEFb homologs and the
yeast U2 snRNP, particularly in transcription. Our findings do not
eliminate the possibility that the U2 snRNP plays some role in
transcription, perhaps of specific genes under specific conditions
not tested in this study. However, if such a role exists, it does not
appear to generally involve interactions with the Bur or Ctk
complexes or their characterized roles in transcription.
Although there were already suggestions in the literature that
transcription and, in particular, the CTD of RNAPII could affect
splicing, the work by Fong & Zhou was the first to demonstrate that
specific interactions between the splicing and transcription machin-
eries led to a reciprocal relationship between transcription and
splicing. These in vitro studies suggested that a similar interaction
occurs in vivo, perhaps to couple transcription and splicing. However,
a parallel in vivo relationship between the core splicing machinery—
namely the U2 snRNP—and P-TEFb has not yet been established.
Interestingly, the SR protein SC35 does facilitate P-TEFb recruit-
ment to specific genes in vivo, and SC35 depletion is associated with
reduced CTD Ser2 and defective transcription elongation [12].
Tat-SF1 has been implicated in both viral transcription and
splicing, as well as in general elongation [63–65]. However, the in
vivo role of Tat-SF1 remains to be fully elucidated. Several in vitro
studies have suggested a role for Tat-SF1 in HIV-1 Tat-
transactivation [63,64]. Furthermore, in vivo data has suggested
instead that Tat-SF1 has important post-transcriptional roles in
regulating viral RNAs. In fact, one recent report suggests that Tat-
SF1 affects HIV-1 replication by regulating the splicing, but not
the transcription, of viral transcripts, while another demonstrates
that Tat’s roles in HIV1 transcription and splicing are functionally
uncoupled and that Tat-SF1 facilitates Tat’s role in the splicing of
viral transcripts [66,67]. Moreover, Tat-SF1 was shown to
facilitate influenza replication via its role in viral packaging, as
opposed to having a role in viral RNA synthesis [17]. Taken
together, these in vivo studies demonstrate that the important
cellular role of Tat-SF1 includes, and may primarily in post-
transcriptional regulation of RNAs, like splicing. Indeed, Tat-SF1,
along with other transcription factors, has been detected in some
complexes containing splicing factors [68], and Tat-SF1 co-
immunoprecipitates with the splicing factor SF3a66 [16]. A
parallel relationship exists between Cus2 and Prp11, the yeast
homolog of SF3a66, and suggests that Tat-SF1 may have roles in
splicing similar to those of Cus2 [16]. Future studies will be needed
Figure 5. Neither Cus2 nor the U2 snRNA co-immunoprecipitate the Bur complex. Anti-His and anti-TAP immunoprecipitations were
performed on whole cell lysates made from formaldehyde cross-linked Bur2-TAP tagged strains carrying a vector or a 66His tagged GAL1-CUS2
plasmid grown in galactose media. The presence or absence of the epitope tag is denoted by a ‘‘+’’ or ‘‘2,’’ respectively. ‘‘IN’’ indicates the input
sample, ‘‘IP’’ indicates the immunoprecipitate. Samples were split and analyzed in parallel for protein interactions by western blotting (WB) and for
protein-RNA interactions by primer extension (PE). In the upper panel, the precipitates were blotted with anti-TAP antibody for detection of the Bur2
protein (indicated by the arrow). In the middle panel, precipitates were blotted with anti-His antibody for detection of Cus2 protein. In the bottom
panel, total RNA from the precipitates was extracted and probed by primer extension for the presence of U snRNAs using oligos specific to U1, U2,
and U4 snRNAs whose products are indicated by arrows. ‘‘*’’ indicates a non-specific product of the primer extension reaction.
doi:10.1371/journal.pone.0016077.g005
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the splicing of endogenous genes.
Is the ability of Tat-SF1 to stimulate viral transcription
evolutionarily conserved?
Although we were unable to demonstrate a clear role for Cus2
in regulating transcription, it is possible that through evolution P-
TEFb and Tat-SF1 have acquired additional functions that allow
them to associate in a novel way not seen in yeast. Although Tat-
SF1 and CUS2 are closely related and contain two highly similar
RRMs, the extensive C-terminal acidic domain of Tat-SF1 is
greatly reduced in Cus2. It is possible that this longer acidic has
allowed Tat-SF1 to acquire a new functions absent in its yeast
counterpart. The acidic domain of Tat-SF1 is required to facilitate
the protein’s association with P-TEFb and for efficient transactiva-
tion of a TAR-containing reporter. In yeast, this portion of the
Cus2 protein is important for its function in U2 snRNA folding as
deletion of this region results in reduced function toward misfolded
U2 snRNA [16]. The extended acidic domain of Tat-SF1 is
therefore an attractive candidate for the region of the protein that
coordinates splicing and transcription.
Interestingly, a recent report identified Cus2 as an important
factor for influenza virus RNA synthesis in infected yeast cells [17].
Here, yeast cells supporting the replication and transcription of the
influenza genome demonstrated lowered viral RNA expression in
the absence of CUS2. This effect was recapitulated with siRNA-
mediated knockdown of Tat-SF1 in influenza infected HeLa cells
due to a direct role for Tat-SF1 in facilitating assembly of viral
RNPs that are essential for downstream viral RNA synthesis. These
data suggest that viral machineries are able to utilize Cus2 and Tat-
SF1 in a similar manner through recognition of homologous
portions of these proteins rather than the extended C-terminal
acidic domain. It is clear that at least in some cases, viruses utilize
host factors in ways unique to viral infection. It will be interesting to
determine whether the effects of Cus2 and Tat-SF1 on influenza
replication are extended to other viruses like HIV1.
In summary, the data reported here are inconsistent with a
general role for the U2 snRNP in regulating transcription in yeast,
but do not preclude the idea that viruses are able to utilize splicing
factors in novel ways to facilitate viral replication. Future studies
will be needed to determine whether Tat-SF1 plays a role in
coupling splicing and transcription of endogenous genes and to
clarify the precise conditions under which this coupling occurs.
Materials and Methods
Yeast strains and growth
The strains used in this study are listed in Table S1 in Supporting
Information S1 and are in the BY4743 strain background with the
exception of the spt and bur mutant strains, provided by Karen Arndt
and Gregory Prelich. Strains containing multiple disruptions with the
same auxotrophic marker were obtained from genetic crosses and
confirmed by PCR. All strains were propagated according to
standard procedures in the appropriate selective media. Plasmid
shuffling was performed on selective 5- fluoroorotic acid (5-FOA)
plates. Sucrose plates prepared as described elsewhere [69] and
supplemented with 1 mg/ml antimycin A. Inositol media were
prepared from a yeast nitrogen base containing ammonium sulfate
but lacking inositol (QBIOgene) and supplemented with the
appropriate nutrients; inositol was added to 100 mM where indicated.
Standard methods for transformations and media preparation were
used as described in Methods in Yeast Genetics: A Cold Spring
Harbor Laboratory Course Manual. The plasmids used in this study
are listed in Table S2 in Supporting Information S1.
Viability assay/dilution series
For growth analysis, strains were grown overnight in the
appropriate selective media at 30uC. Cells were diluted and incubated
at 30uC until all strains reached the same O.D.600 (between 0.3–0.5).
A ten-fold serial dilution of each strain was spotted onto the proper
selective plates and incubated for the indicated number of days.
6-azauracil plate assay
The yeast strains used in this assay were transformed with the
URA3 CEN plasmid pRS316 or a URA3+ 2m plasmid, and selected
on synthetic complete media lacking uracil. The transformed
colonies were grown in SC-uracil liquid media up to O.D.600 of
approximately 0.5, serially diluted 10-fold onto SC-uracil plates
with or without 100 mg/ml 6-azauracil. Plates were incubated at
30uC for 3–6 days.
Cross-linking co-immunoprecipitation
Protein and RNA co-immunoprecipitation experiments were
carried out as described in [70] with the following modifications.
Cells were grown in SC-uracil 2% raffinose to an O.D.600 of
approximately 0.4. Cus2 expression was induced by the addition
of galactose to a final concentration of 2% and incubated for an
additional 3 hours. Cells were cross-linked for 15 minutes with
formaldehyde to a final concentration of 1%. The cells were then
harvested by centrifugation, washed, and lysed by vortexing with
glass beads in cold lysis buffer (50 mM HEPES-KOH pH 7.5,
140 mM NaCl, 1 mM EDTA pH 8.0, 1% Triton-X, 0.1%
Deoxycholate; Roche Complete protease inhibitor, and 40U
Promega RNasin). Pre-cleared whole cell extracts were incubated
for 2.5 hours at 4uC with IgG Sepharose 6 Fast Flow beads (GE
Healthcare) or NiNTA beads (Qiagen) as appropriate. Beads were
washed as previously described and divided into two samples for
subsequent protein or RNA analysis. For protein analysis, the
bound protein was eluted by boiling the beads for 10 minutes in
SDS-PAGE sample buffer. Samples were fractionated by SDS-
PAGE electrophoresis and transferred to a nitrocellulose mem-
brane for immunoblotting with 1:3000 dilution of anti-TAP
(Upstate 12–342) and 1:5000 dilution of anti-His (Santa Cruz
Biotechnology 804), followed by chemiluminescent detection
(Pierce). For RNA analysis, the co-immunoprecipitated RNA
was eluted as described by Selth et al., isolated by phenol
chloroform extraction, and ethanol precipitated. The precipitated
RNA was used as a template for primer extension using oligomers
complementary to the U1, U2, and U4 snRNAs. The sequences of
these primers are listed in Table S3 in Supporting Information S1.
Supporting Information
Supporting Information S1
(DOC)
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